Annett Helleskov Rasmussen

ORCID: 0000-0001-7122-4114
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes Management and Research
  • Streptococcal Infections and Treatments
  • Cardiac Valve Diseases and Treatments
  • Metabolism and Genetic Disorders
  • Neonatal and Maternal Infections
  • Orthopedic Infections and Treatments
  • Neonatal Respiratory Health Research
  • Cerebral Venous Sinus Thrombosis
  • Pancreatic and Hepatic Oncology Research
  • Child and Adolescent Health
  • Neonatal and fetal brain pathology
  • Pneumonia and Respiratory Infections
  • Pharmaceutical studies and practices
  • Pediatric Urology and Nephrology Studies
  • Esophageal and GI Pathology
  • Cardiac and Coronary Surgery Techniques
  • Child Nutrition and Feeding Issues
  • Glaucoma and retinal disorders
  • melanin and skin pigmentation
  • Ocular Diseases and Behçet’s Syndrome
  • Otolaryngology and Infectious Diseases
  • Dysphagia Assessment and Management
  • Neuroblastoma Research and Treatments

Odense University Hospital
2017-2024

Lillebaelt Hospital
2023

University of Southern Denmark
2017

Kolding Hospital
2011

Focal congenital hyperinsulinism (CHI) is curable by surgery, which why identification of the focal lesion crucial. We aimed to determine use 18F-fluoro-dihydroxyphenylalanine (18F-DOPA) PET/CT vs. 68Ga-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic-acid-1-Nal3-octreotide (68Ga-DOTANOC) as diagnostic tools in CHI.PET/CT scans children with CHI admitted Odense University Hospital between August 2005 and June 2016 were retrospectively evaluated visually their maximal standardized uptake...

10.1007/s00259-017-3867-1 article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2017-11-08

Abstract The long-term consequences of transient neonatal hypoglycemia are sparsely studied. We performed a follow-up cohort neonates with blood glucose recordings < 1.7 mmol/L (< 30 mg/dL), treated > 2.5 (> 45 compared healthy siblings. Exclusion criteria were gestational age 35 weeks, severe asphyxia, head injury, and other cerebral diseases. In 71 children 32 control siblings, Wechsler IV cognitive test, Movement ABC-2 Child Behavior Checklist at mean 7.75 9.17 years,...

10.1007/s00431-020-03729-x article EN cc-by European Journal of Pediatrics 2020-07-14

Children with bone and joint infections are traditionally treated intravenous antibiotics for 3-10 days, followed by oral antibiotics. Oral-only treatment has not been tested in randomised trials. (3 months to 18 years) will be 1:1 the experimental group receiving high-dose control a shift both groups standard after clinical paraclinical improvement. need of acute surgery or systemic features requiring therapy, including septic shock, excluded. The primary outcome is defined as normal...

10.1136/bmjopen-2023-072622 article EN cc-by-nc BMJ Open 2023-06-01

Chronic myeloid leukemia (CML) is a rare disease in children and adolescents clinical presentations are variable . Symptoms often attributable to anemia splenomegaly. We present case of secondary pseudotumor cerebri syndrome as the presenting feature pediatric patient with CML review previous cases. Through these cases, we discuss this but important manifestation chronic CML, its cause management. conclude that an differential diagnosis patients it may result permanent visual loss if not...

10.22541/au.165492363.33762563/v1 preprint EN Authorea (Authorea) 2022-06-11
Coming Soon ...